|
Year
|
Award
|
Title
|
Recipient
|
Institution
|
Amount
|
|
1995-1996
|
Karin
Smith/GCF Research Project in Ovarian Cancer
|
Characterization
of a Novel Ovarian Inhibitory Substance
|
Beth
Karlan, M.D.
|
Cedars-Sinai
Medical Center
Los Angeles, CA
|
$50,000
|
|
1995-1996
|
GCF/Ethicon
Research Project in Surgery
|
Adhesion
Formation After Transperitoneal Laparoscopic Pelvic Lymphadenectomy
vs. Extraperitoneal Laparotomy
|
Jeffrey
Fowler, M.D
|
Ohio
State
Columbus, OH
|
$50,000
|
| 1996-1997 |
Karin
Smith/GCF Research Project in Ovarian Cancer |
Adenovirus-Mediated
Gene Therapy of Human Ovarian Cancer |
Stephen
Rubin, M.D. |
Univ.
Of Pennsylvannia
Philadelphia, PA |
$50,000 |
| 1996-1997 |
GCF/Ethicon
Research Project in Surgery |
Comparative
Study of Crystalloid vs. Albumin Replacement in Patients with Ovarian
Cancer and Ascites |
T.
Scott Jennings, M.D. |
Charleston,
SC |
$50,000 |
| 1997-1998 |
Karin
Smith/GCF Research Project in Ovarian Cancer |
Molecular-Epidemiology
of Ovarian Cancer |
Andrew
Berchuck, M.D. |
Duke
University
Durham, NC |
$50,000 |
| 1997-1998 |
Florence
& Marshall Schwid/GCF Research Project in Ovarian Cancer |
Modulation
of BRCA1 Expression in Ovarian Cancer: Screening Ramifications |
Richard
Buller, M.D. |
University
of Iowa
Iowa City, IA |
$50,000 |
| 1997-1998 |
Eva
Metzger/GCF Research Project in Ovarian Cancer |
Regulation
of Ovarian Cancer Cell Growth with Cyclin Dependent Kinase Inhibitor
Gene Therapy |
Jean
A. Hurteau, M.D. |
University
Hospital
Indianapolis, IN |
$50,000 |
| 1997-1998 |
GCF
Research Grant in Gynecologic Cancer |
"Evaluation
of the Effect and Mechanism of Action of Adenovirus-Mediated Tumor
Suppresor Gene Therapy of Ovarian Cancer" |
Judith
Wolf, M.D. |
M.D.
Anderson Cancer
Houston, TX |
$25,000 |
| 1998-1999 |
Florence
& Marshall Schwid/GCF Research Project in Ovarian Cancer |
A
Molecular Fingerprint of Angiogenesis in Epithelial Ovarian Cancer |
Pamela
Paley, M.D. |
University
of Washington
Seattle, WA |
$50,000 |
| 1999-2000 |
Florence
& Marshall Schwid/GCF Research Project in Ovarian Cancer |
A
Dendritic Cell-based Vaccine Strategy for Ovarian Carcinoma Using
the Novel Ovarian Tumor Marker Mesothelin |
Terri
B. Pustilnik, M.D. |
University
of Alabama
Birmingham, AL |
$50,000 |
| 2000-2001 |
Florence
& Marshall Schwid/GCF Research Project in Ovarian Cancer |
Evaluation
of MKK4/SEKI Metastasis Suppressor Gene in Ovarian Carcinoma |
S.
Diane Yamada, M.D. |
University
of Chicago
Chicago, IL |
$50,000 |
| 2000-2001 |
GCF/Bristol-Myers
Squibb Oncology Young Investigator Award |
Impact
of Cytotoxic Chemotherapy on the Development of Immune Therapy Strategies
in Epitelial Ovarian Cancer |
George
Coukos, M.D., Ph.D. |
University
of Pennsylvania
Philadelphia, PA |
$50,000 |
| 2000-2001 |
GCF/NOCC
Ovarian Cancer Research Grant |
Role
of FAK expression in invasion and Cisplatin resistance in ovarian
cancer |
Anil
K. Sood, M.D. |
University
of Iowa
Iowa City, IA |
$50,000 |
| 2000-2002 |
GCF/Susan
G. Komen Breast Cancer Foundation Career Development Award |
Effect
of p53 mutation status on cisplatin chemosensitivity in carcinomas
with BRCA1 mutations |
Ilana
Cass, M.D. |
Cedars
Sinai Medical Ctr.
Los Angeles, CA |
$50,000
for 2 yrs. |
| 2001-2002 |
Florence
& Marshall Schwid/GCF Research Project in Ovarian Cancer |
Impact
of Epigenetic Modulation on DNA Repair Genes on Chemoresistance and
Survival in Ovarian Cancer |
Elizabeth
M. Swisher, MD |
Univ.
of Washington
Seattle, WA |
$50,000 |
| 2001-2002 |
GCF/Bristol-Myers
Squibb Oncology Young Investigator Award |
Transduced
Dendritic Cell Therapy for Cervical Cancer-Alternative Vector Targeting
and Conjugate Strategies |
Warner
K. Huh, MD |
University
of Alabama
Birmingham, AL |
$50,000 |
| 2001-2002 |
GCF/NOCC
Ovarian Cancer Research Grant |
Validation
of an Avian Ovarian Cancer Model" |
William
A. Cliby, MD |
Mayo
Clinic
Rochester, MN |
$50,000 |